作者：
Mendel,Kaelen [1]
;
Leor,Roseman [2]
;
Joshua,Kahan [3]
;
Andre,Santos-Ribeiro [4]
;
Csaba,Orban [4]
;
Romy,Lorenz [5]
;
Frederick S,Barrett [6]
;
Mark,Bolstridge [4]
;
Tim,Williams [7]
;
Luke,Williams [4]
;
Matthew B,Wall [8]
;
Amanda,Feilding [9]
;
Suresh,Muthukumaraswamy [10]
;
David J,Nutt [4]
;
Robin,Carhart-Harris [4]
作者单位：
Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London W12, UK. Electronic address: m.kaelen@imperial.ac.uk.
[1]
Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London W12, UK; The Computational, Cognitive and Clinical Neuroimaging Laboratory, The Centre for Neuroscience, Division of Brain Sciences, Imperial College London, London W12, UK.
[2]
Sobell Department of Motor Neuroscience & Movement Disorders, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK.
[3]
Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London W12, UK.
[4]
The Computational, Cognitive and Clinical Neuroimaging Laboratory, The Centre for Neuroscience, Division of Brain Sciences, Imperial College London, London W12, UK.
[5]
Behavioral Pharmacology Research Unit, Johns Hopkins School of Medicine, Baltimore, MD 21224, USA.
[6]
Academic Unit of Psychiatry, University of Bristol, Bristol BS8 2BN, UK.
[7]
Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London W12, UK; Imanova Centre for Imaging Sciences, Hammersmith Hospital, London W12, UK; Clinical Psychopharmacology Unit, University College London, London UK.
[8]
The Beckley Foundation, Beckley Park, Oxford OX3 9SY, UK.
[9]
Schools of Pharmacy and Psychology, University of Auckland, Auckland 1142, New Zealand.
[10]
DOI
10.1016/j.euroneuro.2016.03.018
PMID
27084302
发布时间
2022-03-21
换一批
换一批
